Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
- PMID: 9359705
- DOI: 10.1038/nm1197-1275
Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
Abstract
The multidrug resistance-associated protein (MRP) mediates the cellular excretion of many drugs, glutathione S-conjugates (GS-X) of lipophilic xenobiotics and endogenous cysteinyl leukotrienes. Increased MRP levels in tumor cells can cause multidrug resistance (MDR) by decreasing the intracellular drug concentration. The physiological role or roles of MRP remain ill-defined, however. We have generated MRP-deficient mice by using embryonic stem cell technology. Mice homozygous for the mrp mutant allele, mrp-/-, are viable and fertile, but their response to an inflammatory stimulus is impaired. We attribute this defect to a decreased secretion of leukotriene C4 (LTC4) from leukotriene-synthesizing cells. Moreover, the mrp-/- mice are hypersensitive to the anticancer drug etoposide. The phenotype of mrp-/- mice is consistent with a role for MRP as the main LTC4-exporter in leukotriene-synthesizing cells, and as an important drug exporter in drug-sensitive cells. Our results suggest that this ubiquitous GS-X pump is dispensable in mice, making treatment of MDR with MRP-specific reversal agents potentially feasible.
Similar articles
-
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.Biochem Biophys Res Commun. 1998 Jun 29;247(3):859-63. doi: 10.1006/bbrc.1998.8887. Biochem Biophys Res Commun. 1998. PMID: 9647783
-
The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion.Adv Enzyme Regul. 1996;36:17-29. doi: 10.1016/0065-2571(95)00011-9. Adv Enzyme Regul. 1996. PMID: 8869738
-
Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.Mol Pharmacol. 1997 Sep;52(3):344-53. doi: 10.1124/mol.52.3.344. Mol Pharmacol. 1997. PMID: 9281595
-
Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?Semin Cancer Biol. 1997 Jun;8(3):205-13. doi: 10.1006/scbi.1997.0071. Semin Cancer Biol. 1997. PMID: 9441949 Review.
-
[Multidrug resistance protein (MRP)].Nihon Rinsho. 1997 May;55(5):1077-82. Nihon Rinsho. 1997. PMID: 9155156 Review. Japanese.
Cited by
-
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.PLoS One. 2016 May 12;11(5):e0155013. doi: 10.1371/journal.pone.0155013. eCollection 2016. PLoS One. 2016. PMID: 27171227 Free PMC article.
-
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.Respir Res. 2006 Nov 21;7(1):137. doi: 10.1186/1465-9921-7-137. Respir Res. 2006. PMID: 17118201 Free PMC article.
-
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma.Med Oncol. 2002;19(2):87-104. doi: 10.1385/MO:19:2:87. Med Oncol. 2002. PMID: 12180485
-
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion.J Exp Med. 2002 Sep 16;196(6):841-50. doi: 10.1084/jem.20020516. J Exp Med. 2002. PMID: 12235216 Free PMC article.
-
A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation.Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2220012120. doi: 10.1073/pnas.2220012120. Epub 2023 Mar 9. Proc Natl Acad Sci U S A. 2023. PMID: 36893260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
